key: cord-0842930-cp7qz2ys
authors: Pfefferle, Susanne; Günther, Thomas; Kobbe, Robin; Czech-Sioli, Manja; Nörz, Dominic; Santer, René; Oh, Jun; Kluge, Stefan; Oestereich, Lisa; Peldschus, Kersten; Indenbirken, Daniela; Huang, Jiabin; Grundhoff, Adam; Aepfelbacher, Martin; Knobloch, Johannes K.; Lütgehetmann, Marc; Fischer, Nicole
title: SARS-CoV-2 variant tracing within the first COVID-19 clusters in Northern Germany
date: 2020-09-29
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2020.09.034
sha: c2ca2c699b0b9029b4e654a27fb3b6ba8f5d2717
doc_id: 842930
cord_uid: cp7qz2ys

OBJECTIVES: Investigation whether in depth characterization of virus variant patterns can be used for epidemiological analysis of the first SARS-CoV-2 infection clusters in Hamburg, Germany. METHODS: Metagenomic RNA- and amplicon-sequencing and subsequent variant calling in 25 respiratory samples from SARS-CoV-2 infected patients involved in the earliest infection clusters in Hamburg. RESULTS: Amplikon sequencing and cluster analyses of these SARS-CoV-2 sequences allowed the identification of the first infection cluster and five non-related infection clusters occurring at the beginning of the viral entry of SARS-CoV-2 in the Hamburg metropolitan region. Viral genomics together with epidemiological analyses revealed that the index patient acquired the infection in Northern Italy and transmitted it to two out of 134 contacts. Single nucleotide polymorphisms clearly distinguished the virus variants of the index and other clusters and allowed to track in which sequences worldwide these mutations were first described. Minor variant analyses identified the transmission of intra-host variants in the index cluster and household clusters. CONCLUSIONS: SARS-CoV-2 variant tracing allows the identification of infection clusters and the follow up of infection chains occurring in the population. Furthermore, the follow up of minor viral variants in infection cluster can provide further resolution on transmission events indistinguishable on consensus sequence level.

Clustering is mostly driven by SNPs located in the leader region (nt 241), nsp3 (nt 3037), RNApol (nt 96 14408) and spike (nt 23403; D614G). These co-occurring mutations have been recently described as 97 one major variant occurring in Europe (8), referred to as genotype II (4). Sub-patterns, II.2-II.4 are 98 defined by additional SNPs, with different frequencies according to GISAID entries ( Figure 1B) . 99

We used the SNP information in the context of GISAID sequences to reproduce the geographic origins 100 of the viral sequences ( Figure 1B) . SNPs defining pattern II.1 (returnees from clubbing in Berlin) have 101 been first described in a sequence sampled in Italy. Within pattern II.2, the index cluster is defined by 102 an additional SNP, nt 160, a variant not described at that time. This mutation in combination with 103 details from questionnaires and time course of positivity strongly suggests that P01 and P02 acquired 104

Rhine Westphalia, Germany. Finally, pattern I, a sequence from a travel returnee from the Middle East 114 shows 12 SNPs with six of them being previously reported in a sequence sampled in Oman. 115

Based on amplicon-sequencing, we defined minority variants, sub-consensus viral populations, at 14 116 positions with ten resulting in synonymous mutations. 117

Interestingly, in two family clusters, we identified minority variants allowing us to follow transmission By following the transmission of intra-host variants, we propose high dose transmission of SARS-143

CoV-2 occurring in these clusters. In contrast to our study, no evidence of transmission of intra-host 144 variants has been described in a previous study (12) while in another study identical minor variants 145 were identified in household and workplace clusters (13). 146

Overall, our study describes the initial SARS-CoV-2 clusters occurring in Hamburg and emphasizes 147 that virus variant tracing can provide further resolution for the identification of transmission events, 148 e.g. in clusters that are indistinguishable at the consensus sequence level. 149 150

These differences may be explained by our variant calling approach, employing >33 % variant 141 frequencies as cut-off

A Novel Coronavirus from Patients 170 with Pneumonia in China

Global initiative on sharing all influenza data -from vision to 172 reality

On the origin and continuing evolution of 174 SARS-CoV-2. National Science Review

Genotyping coronavirus SARS-CoV-2: methods and implications

Evolution 177 and epidemic spread of SARS-CoV-2 in Brazil

Genomic surveillance 179 reveals multiple introductions of SARS-CoV-2 into Northern California

Spread of SARS-CoV-2 in the Icelandic Population

Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Evaluation of a quantitative RT-PCR assay 187 for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system

CoV-2 diversity suggests localised transmission of minority variants

and 19 SARS-CoV-2 sequences from respiratory swabs collected in the 203 same time period in comparison to the reference sequence, NC_045521. Nucleotide positions are 204 indicated at the bottom. Included are only variants with sufficient coverage (>10) and SNP being 205 present in more than 33 % of all reads in at least one sample. I-III summarizes sequence patterns as 206 defined by SNPs. The frequency of variants is indicated by the heat map ranging from grey 207 (reference), yellow to dark blue (variant). The quality score per individual site is indicated at the top. * 208 indicates members within one family. Sampling dates are indicated on the right with the sampling date 209 of the cases in the index cluster labeled in red. (B) Overview of individual SNPs defining pattern I

We thank Svenja Reucher and Kerstin Reumann for excellent technical support and Uwe Ganz for 153 graphical illustration. We gratefully acknowledge the authors, originating and submitting laboratories 154 of the sequences from GISAID's EpiFlu™ Database1 on which part of this research is based. 155